Pre-eclampsia almost doubles vascular dementia risk in later life: study
Women with a history of pre-eclampsia are nearly twice as likely to develop vascular dementia than those who had normotensive pregnancies, data from over two…
Specialist Updates
In-depth coverage of specialist medicine
Opioid exposure linked to higher preterm birth risk
Opioid exposure is associated with increased odds of spontaneous preterm birth, according to a US study in JAMA Network Open. Researchers from Vanderbilt University in…
Gliflozins beat other T2DM drugs for lowering kidney stone risk: study
For adults with type 2 diabetes, initiation of SGLT2 inhibitors may lower the risk for nephrolithiasis, according to a US study in JAMA Internal Medicine.…
Doctors call for inquiry into rising perinatal deaths
A leading obstetrician is calling for a national inquiry into maternity care after new data revealed the perinatal death rate in Queensland had jumped by…
‘Lack of scientific rigour’: Journal retracts studies cited in US medical abortion access case
Two studies that warned of the harms of medical abortion have been retracted by the journal’s publisher over flaws in the data and conflicts of…
Secondary primary malignancies ‘rare’ after CAR T-cell immunotherapy
The incidence of secondary primary malignancy after anti-CD19 chimeric antigen receptor T-cell immunotherapy is very low, according to a study in Nature Medicine. US researchers…
Offer compression sleeves to prevent breast cancer–related arm lymphoedema: new guidance
Patients at risk of developing arm lymphoedema after breast cancer treatment should be offered prophylactic compression sleeves, according to world-first guidance. Axillary reverse mapping and…
‘We did not expect these results’: Testosterone therapy linked to higher fracture risk
Testosterone treatment may increase fracture risk in middle-aged and older men with hypogonadism, according to new research that contradicts conventional wisdom. While exogenous testosterone has…
Alpha therapy a ‘viable option’ for metastatic castration-resistant prostate cancer
Targeted alpha therapy is safe and effective for treating metastatic castration-resistant prostate cancer when other anticancer agents have failed, show results from the largest trial…
Chemotherapy plus dose-escalated radiation shows promise for advanced NSCLC: study
Chemoradiation with an adaptive stereotactic ablative radiotherapy boost is safe and effective for patients with locally advanced, unresectable non-small cell lung cancer, according to a…
